- Home
- RADX vs CLPS Comparison
RADX vs CLPS Comparison
Compare RADX & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RADX
- CLPS
- Stock Information
- Founded
- RADX 2021
- CLPS 2005
- Country
- RADX Australia
- CLPS Hong Kong
- Employees
- RADX N/A
- CLPS N/A
- Industry
- RADX
- CLPS Computer Software: Prepackaged Software
- Sector
- RADX
- CLPS Technology
- Exchange
- RADX NYSE
- CLPS Nasdaq
- Market Cap
- RADX 32.5M
- CLPS 26.9M
- IPO Year
- RADX N/A
- CLPS 2018
- Fundamental
- Price
- RADX $4.64
- CLPS $0.92
- Analyst Decision
- RADX Strong Buy
- CLPS
- Analyst Count
- RADX 3
- CLPS 0
- Target Price
- RADX $15.00
- CLPS N/A
- AVG Volume (30 Days)
- RADX 18.6K
- CLPS 11.0K
- Earning Date
- RADX 02-26-2025
- CLPS 03-05-2025
- Dividend Yield
- RADX N/A
- CLPS 13.71%
- EPS Growth
- RADX N/A
- CLPS N/A
- EPS
- RADX N/A
- CLPS N/A
- Revenue
- RADX $204,609.00
- CLPS $153,816,045.00
- Revenue This Year
- RADX N/A
- CLPS N/A
- Revenue Next Year
- RADX N/A
- CLPS N/A
- P/E Ratio
- RADX N/A
- CLPS N/A
- Revenue Growth
- RADX N/A
- CLPS 5.81
- 52 Week Low
- RADX $3.50
- CLPS $0.68
- 52 Week High
- RADX $50.82
- CLPS $1.70
- Technical
- Relative Strength Index (RSI)
- RADX N/A
- CLPS 42.16
- Support Level
- RADX N/A
- CLPS $0.92
- Resistance Level
- RADX N/A
- CLPS $1.00
- Average True Range (ATR)
- RADX 0.00
- CLPS 0.05
- MACD
- RADX 0.00
- CLPS -0.00
- Stochastic Oscillator
- RADX 0.00
- CLPS 15.32
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.